Please assess the completion status of the following clinical trial:

Trial Title: Standard Total Knee Arthroplasty Using Platelet Rich Plasma (PRP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is a male or female who is undergoing primary unilateral surgery or the first surgery of a staged bilateral total knee replacement where the second stage will be at least 6 weeks later~* Patient agrees to be blinded to their treatment group assignment~* Patient is willing and able to return for follow-up over at least a six (6) month post-operative period although longer follow-up may be desired~* Patient agrees to participate by signing an IRB approved Informed Consent Form~Exclusion Criteria:~* Patient will have a staged bilateral total knee replacement with the second stage to be performed less than 6 weeks after the first stage surgery PRP in~* Patient has had previous surgery on the operative knee that will necessitate the removal of existing hardware (e.g. previous osteotomy)~* Patient has a known adverse reaction or sensitivity to bovine (cow) thrombin (used as part of the platelet rich plasma system) or other bovine-derived products~* Patient has hemoglobin \< 12.0 (males), \< 11.0 (females)~* Patient has a clinically significant anxiety disorder~* Patient is on therapeutic anticoagulation medication and has an INR \> 1.3~* Patient has a severe bleeding disorder~* Patient has a known addiction to drugs or alcohol, including, but not limited to: chronic daily use of narcotic medications for more than 90 days prior to surgery~* Patient is pregnant~* Patient is a prisoner~* Patient is involved in a personal litigation (e.g. Worker's Compensation) that relates to their knee surgery~* Patient is actively participating in another medical device, drug, or biologic clinical trial (active defined as having treatment within the last 30 days)

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard TKA (Type: ACTIVE_COMPARATOR): Subjects in this arm will receive total knee replacement as standard of care without Platte Rich Plasma
- Standard TKA with PRP (Type: ACTIVE_COMPARATOR): Subjects in this arm will receive total knee replacement as standard of care with Platte Rich Plasma

Based on this trial design, predict the completion outcome and termination type (if applicable).